HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chad Huff Selected Research

Chromatin

1/2021Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chad Huff Research Topics

Disease

5Neoplasms (Cancer)
01/2021 - 08/2011
2Melanoma (Melanoma, Malignant)
01/2017 - 05/2016
1Breast Neoplasms (Breast Cancer)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
01/2021
1Adenocarcinoma
01/2019
1And Genital Anomalies Adrenal Hypoplasia Congenita Metaphyseal Dysplasia Intrauterine Growth Retardation
12/2018
1Lung Neoplasms (Lung Cancer)
11/2016
1Carcinogenesis
05/2016
1Alternating hemiplegia of childhood
01/2015
1Dystonia 12
09/2012
1Inborn Genetic Diseases (Disease, Hereditary)
08/2011
1Neurofibromatoses (Neurofibromatosis)
08/2011
1Hemophilia A (Haemophilia)
08/2011

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2017
2Adenosine Triphosphatases (ATPase)IBA
01/2015 - 09/2012
1Peptides (Polypeptides)IBA
01/2021
1ORALIT (ORS)IBA
01/2021
1Cell-Penetrating PeptidesIBA
01/2021
1ChromatinIBA
01/2021
1dacomitinibIBA
01/2019
1DNA Polymerase IIIBA
12/2018
1Indicators and Reagents (Reagents)IBA
01/2017
15-Methylcytosine (5 Methylcytosine)IBA
01/2017
1C-Reactive ProteinIBA
11/2016
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2016
1Biomarkers (Surrogate Marker)IBA
11/2016
1BilirubinIBA
11/2016
1Carcinoembryonic AntigenIBA
11/2016
1Mitochondrial DNA (mtDNA)IBA
05/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2016
1Proteins (Proteins, Gene)FDA Link
09/2012
1ElementsIBA
08/2011

Therapy/Procedure

1Therapeutics
01/2021